• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种空间疫苗接种策略,以降低疫苗耐药变体的风险。

A spatial vaccination strategy to reduce the risk of vaccine-resistant variants.

机构信息

Department of Physics, Jinan University, Guangzhou, China.

Department of Molecular Genetics, Weizmann Institute of Science, Israel.

出版信息

PLoS Comput Biol. 2022 Aug 10;18(8):e1010391. doi: 10.1371/journal.pcbi.1010391. eCollection 2022 Aug.

DOI:10.1371/journal.pcbi.1010391
PMID:35947602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9394842/
Abstract

The COVID-19 pandemic demonstrated that the process of global vaccination against a novel virus can be a prolonged one. Social distancing measures, that are initially adopted to control the pandemic, are gradually relaxed as vaccination progresses and population immunity increases. The result is a prolonged period of high disease prevalence combined with a fitness advantage for vaccine-resistant variants, which together lead to a considerably increased probability for vaccine escape. A spatial vaccination strategy is proposed that has the potential to dramatically reduce this risk. Rather than dispersing the vaccination effort evenly throughout a country, distinct geographic regions of the country are sequentially vaccinated, quickly bringing each to effective herd immunity. Regions with high vaccination rates will then have low infection rates and vice versa. Since people primarily interact within their own region, spatial vaccination reduces the number of encounters between infected individuals (the source of mutations) and vaccinated individuals (who facilitate the spread of vaccine-resistant strains). Thus, spatial vaccination may help mitigate the global risk of vaccine-resistant variants.

摘要

新冠疫情表明,针对新型病毒的全球疫苗接种过程可能会很漫长。最初为控制疫情而采取的社交距离措施,随着疫苗接种的推进和人群免疫力的提高,逐渐放宽。其结果是疾病流行期延长,同时具有疫苗抗性变异的适应优势,这两者共同导致疫苗逃逸的可能性大大增加。提出了一种空间疫苗接种策略,有可能显著降低这种风险。该策略不是在全国范围内均匀分散疫苗接种工作,而是按顺序对国家的不同地理区域进行疫苗接种,迅速使每个区域达到有效的群体免疫。高接种率地区的感染率会较低,反之亦然。由于人们主要在自己的区域内相互作用,因此空间疫苗接种减少了感染个体(突变来源)和接种个体(促进疫苗抗性菌株传播)之间的接触次数。因此,空间疫苗接种可能有助于减轻全球疫苗抗性变异的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/17c81c5faefa/pcbi.1010391.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/74f30da54e0c/pcbi.1010391.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/1af7e19fbf2c/pcbi.1010391.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/1c9c58554da1/pcbi.1010391.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/a6e52bafe03a/pcbi.1010391.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/8eb426cf5896/pcbi.1010391.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/4ab1fe0e8f95/pcbi.1010391.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/06c55c17c517/pcbi.1010391.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/fcde181f9594/pcbi.1010391.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/494db3576874/pcbi.1010391.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/da7e38a54176/pcbi.1010391.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/19daeb9b36c0/pcbi.1010391.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/17c81c5faefa/pcbi.1010391.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/74f30da54e0c/pcbi.1010391.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/1af7e19fbf2c/pcbi.1010391.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/1c9c58554da1/pcbi.1010391.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/a6e52bafe03a/pcbi.1010391.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/8eb426cf5896/pcbi.1010391.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/4ab1fe0e8f95/pcbi.1010391.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/06c55c17c517/pcbi.1010391.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/fcde181f9594/pcbi.1010391.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/494db3576874/pcbi.1010391.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/da7e38a54176/pcbi.1010391.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/19daeb9b36c0/pcbi.1010391.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c38a/9394842/17c81c5faefa/pcbi.1010391.g012.jpg

相似文献

1
A spatial vaccination strategy to reduce the risk of vaccine-resistant variants.一种空间疫苗接种策略,以降低疫苗耐药变体的风险。
PLoS Comput Biol. 2022 Aug 10;18(8):e1010391. doi: 10.1371/journal.pcbi.1010391. eCollection 2022 Aug.
2
Herd immunity: challenges and the way forward in Korea.群体免疫:韩国面临的挑战与前进道路。
Epidemiol Health. 2021;43:e2021054. doi: 10.4178/epih.e2021054. Epub 2021 Aug 18.
3
COVID-19 exit strategy during vaccine implementation: a balance between social distancing and herd immunity.疫苗实施期间的 COVID-19 退出策略:在社交距离和群体免疫之间取得平衡。
Arch Virol. 2022 Sep;167(9):1773-1783. doi: 10.1007/s00705-022-05495-7. Epub 2022 Jun 20.
4
The herd-immunity threshold must be updated for multi-vaccine strategies and multiple variants.群体免疫阈值必须针对多疫苗策略和多种变体进行更新。
Sci Rep. 2021 Nov 26;11(1):22970. doi: 10.1038/s41598-021-00083-2.
5
Achieving herd immunity in South America.在南美洲实现群体免疫。
Glob Health Res Policy. 2023 Feb 1;8(1):2. doi: 10.1186/s41256-023-00286-2.
6
Critical assessment of the impact of vaccine-type and immunity on the burden of COVID-19.对疫苗类型和免疫对 COVID-19 负担影响的批判性评估。
Math Biosci. 2023 Jun;360:108981. doi: 10.1016/j.mbs.2023.108981. Epub 2023 Feb 16.
7
Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.实现美国 COVID-19 疫苗衍生群体免疫阈值
Front Public Health. 2021 Jul 23;9:709369. doi: 10.3389/fpubh.2021.709369. eCollection 2021.
8
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].《中国季节性流感疫苗接种技术指南(2022—2023年)》
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Oct 6;56(10):1356-1386. doi: 10.3760/cma.j.cn112150-20220825-00840.
9
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].《中国季节性流感疫苗接种技术指南(2022—2023年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Oct 10;43(10):1515-1544. doi: 10.3760/cma.j.cn112338-20220825-00734.
10
Assessing the cost-effectiveness of COVID-19 vaccines in a low incidence and low mortality setting: the case of Thailand at start of the pandemic.评估 COVID-19 疫苗在低发病率和低死亡率环境中的成本效益:以大流行初期的泰国为例。
Eur J Health Econ. 2023 Jul;24(5):735-748. doi: 10.1007/s10198-022-01505-2. Epub 2022 Aug 11.

引用本文的文献

1
Overcoming Health Inequities: Spatial Analysis of Seroprevalence and Vaccination Against COVID-19 in Chile.克服健康不平等:智利新冠病毒血清阳性率和疫苗接种情况的空间分析
Health Equity. 2024 Aug 26;8(1):558-567. doi: 10.1089/heq.2023.0204. eCollection 2024.
2
Assessing the impacts of vaccination and viral evolution in contact networks.评估疫苗接种和病毒进化在接触网络中的影响。
Sci Rep. 2024 Jul 8;14(1):15753. doi: 10.1038/s41598-024-66070-5.
3
Correction: A spatial vaccination strategy to reduce the risk of vaccine-resistant variants.

本文引用的文献

1
Evolution of resistance to COVID-19 vaccination with dynamic social distancing.动态社交隔离下对 COVID-19 疫苗接种的耐药性演变。
Nat Hum Behav. 2022 Feb;6(2):193-206. doi: 10.1038/s41562-021-01281-8. Epub 2022 Feb 24.
2
Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario.安大略省针对 COVID-19 疫苗对有症状的 SARS-CoV-2 感染和关注变种的严重后果的有效性。
Nat Microbiol. 2022 Mar;7(3):379-385. doi: 10.1038/s41564-021-01053-0. Epub 2022 Feb 7.
3
Targeted pandemic containment through identifying local contact network bottlenecks.
更正:一种降低疫苗抗性变体风险的空间疫苗接种策略。
PLoS Comput Biol. 2023 Oct 30;19(10):e1011608. doi: 10.1371/journal.pcbi.1011608. eCollection 2023 Oct.
4
Time series analysis of daily reported number of new positive cases of COVID-19 in Japan from January 2020 to February 2023.2020 年 1 月至 2023 年 2 月日本每日新增新冠肺炎确诊病例的时间序列分析。
PLoS One. 2023 Sep 15;18(9):e0285237. doi: 10.1371/journal.pone.0285237. eCollection 2023.
5
Evolutionary safety of lethal mutagenesis driven by antiviral treatment.抗病毒治疗驱动的致死性诱变的进化安全性。
PLoS Biol. 2023 Aug 8;21(8):e3002214. doi: 10.1371/journal.pbio.3002214. eCollection 2023 Aug.
6
Pathogen diversity in meta-population networks.集合种群网络中的病原体多样性
Chaos Solitons Fractals. 2023 Jan;166:112909. doi: 10.1016/j.chaos.2022.112909. Epub 2022 Nov 25.
7
Distribution equality as an optimal epidemic mitigation strategy.分配公平性作为最优的疫情缓解策略。
Sci Rep. 2022 Jun 21;12(1):10430. doi: 10.1038/s41598-022-12261-x.
通过识别本地接触网络瓶颈来实现有针对性的大流行控制。
PLoS Comput Biol. 2021 Aug 30;17(8):e1009351. doi: 10.1371/journal.pcbi.1009351. eCollection 2021 Aug.
4
Rates of SARS-CoV-2 transmission and vaccination impact the fate of vaccine-resistant strains.SARS-CoV-2 的传播率和疫苗接种率影响着疫苗耐药株的命运。
Sci Rep. 2021 Jul 30;11(1):15729. doi: 10.1038/s41598-021-95025-3.
5
SARS-CoV-2 variants, spike mutations and immune escape.SARS-CoV-2 变体、刺突突变和免疫逃逸。
Nat Rev Microbiol. 2021 Jul;19(7):409-424. doi: 10.1038/s41579-021-00573-0. Epub 2021 Jun 1.
6
The universal visitation law of human mobility.人类流动的普遍访问规律。
Nature. 2021 May;593(7860):522-527. doi: 10.1038/s41586-021-03480-9. Epub 2021 May 26.
7
SARS-CoV-2 incidence and vaccine escape.严重急性呼吸综合征冠状病毒2型发病率与疫苗逃逸
Lancet Infect Dis. 2021 Jul;21(7):913-914. doi: 10.1016/S1473-3099(21)00202-4. Epub 2021 Apr 13.
8
Concerns about SARS-CoV-2 evolution should not hold back efforts to expand vaccination.对 SARS-CoV-2 进化的担忧不应阻碍疫苗接种工作的开展。
Nat Rev Immunol. 2021 May;21(5):330-335. doi: 10.1038/s41577-021-00544-9. Epub 2021 Apr 1.
9
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma.SARS-CoV-2 501Y.V2 逃避恢复期血浆中和作用。
Nature. 2021 May;593(7857):142-146. doi: 10.1038/s41586-021-03471-w. Epub 2021 Mar 29.
10
SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)501Y.V2变体的传染性并不更强,但确实存在免疫逃逸。
Cell. 2021 Apr 29;184(9):2362-2371.e9. doi: 10.1016/j.cell.2021.02.042. Epub 2021 Feb 23.